THE ROLE OF HYPOXIA INDUCIBLE FACTOR ALPHA AND ANTI-CYCLIC CITRULLINATED PEPTIDE IN RHEUMATOID ARTHRITIS EGYPTAIN PATIENTS

Anti-Carbamylated antibodies as a marker of activity and disability in Rheumatoid Arthritis

Anti-Carbamylated antibodies as a marker of activity and disability in Rheumatoid Arthritis

Anti-carbamylated protein antibodies in rheumatoid arthritis

COVID-19 among Rheumatoid Arthritis Patients on ‎Immunosuppressive Therapy During the First Wave of the COVID-‎‎19 Pandemic: a Prospective Comparative Study ‎

COVID-19 VACCINE IN EGYPTIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND OTHER RHEUMATIC DISEASES

Anti-cyclic citrullinated peptide antibodies in thediagnosis of rheumatoid arthritis:Correlation with some clinical and laboratory data

The Association Between Anti-Cyclic Citrullinated Peptide and Anti-Mutated Citrullinated Vimentin and The Extra-articular Manifestations in Patients with Rheumatoid Arthritis

Anticyclic citrullinated protein/ peptide antibody assays in rheumatoid arthritis and correlation with disease severity parameters and radiographic damage

Obesity among Rheumatoid Arthritis Patients and its Relation to Disease Activity: Cross-sectional Study among the Egyptian Population